Stock Quote

Allergic Conjunctivitis Market Size 2021 | Is Projected to Reach USD 3.60 Billion by 2028, Exhibiting a CAGR of 5.4%

Pune, India, July 02, 2021 (GLOBE NEWSWIRE) -- The global allergic conjunctivitis market size is projected to reach USD 3.60 billion by 2028, exhibiting a CAGR of 5.4% during the forecast period. The value of the market was estimated to be USD 2.40 billion in 2020 and is expected to touch USD 2.50 billion in 2021, as per the report by Fortune Business Insights™, titled “Allergic Conjunctivitis Market, 2021-2028”.

Increasing Research into Drug Efficacy to Boost the Market

Allergic eye diseases and conditions require the administration of medications that can provide considerable relief from the discomfort and possible pain from these conditions. As a result, a few companies and academic institutions are conducting intensive research to investigate the efficacy of novel therapeutics for ocular allergies. For example, in March 2021, a team from the Shanghai Jiaotong University, China, studied the effectiveness of an innovative delivery system of pemirolast potassium-loaded gellan gum in situ gel for allergic conjunctivitis. The study showed that the gel exhibited excellent stability and did not damage any part of the eye during delivery. In April 2021, according to a study published in the American Journal of Ophthalmology, Dextenza by Ocular Therapeutix can relieve ocular itching in patients suffering from this disease for nearly four weeks. Such studies are raising the potential of novel treatments for this form of conjunctivitis and fueling the growth of the market.


Request a Sample Copy of the Research Report:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/allergic-conjunctivitis-market-100121


Segmentation

By drug class, this market has been trifurcated into antihistamines & mast cell stabilizers, corticosteroids, and others. The corticosteroids segment held a market share of 14.0% in 2020.

In terms of disease type, the market’s segments include mild and severe allergic conjunctivitis. Based on distribution channel, the market has been divided into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies. On the basis of region, the market has been categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

COVID-19 Impact

The outbreak of the COVID-19 pandemic has not boded well for this market as strict lockdowns and apprehensions surrounding the coronavirus have led to a dramatic drop in visits to ophthalmologists by patients. Moreover, with elective procedures suspended by most healthcare facilities worldwide, treatments for mild to moderate ocular conditions have been postponed by doctors and other health professionals. Against the backdrop of these developments, the market growth slumped by -4% in 2020.


Click here to get the short-term and long-term impact of COVID-19 on this market.

Please visit: https://www.fortunebusinessinsights.com/industry-reports/allergic-conjunctivitis-market-100121


What Does the Report Offer?

The report contains a bird’s-eye view analysis of the market trends and drivers, as well as offers a piecemeal study of all individual market segments. Further, the report provides a thorough assessment of the market restraints and also incorporates detailed research into the regional dynamics and competitive landscape of the market.

Regulatory Clearances to Novel Medications to Support Market Growth

Recognizing the need for treating allergic conjunctivitis, regulatory bodies such as the US Food and Drug Administration (FDA) are actively green lighting novel therapies that can effectively tackle the condition and provide relief to patients. For example, in March 2021, Ocular Therapeutix’s DEXTENZA was accepted for review by the USFDA and if approved, the drug would carry an additional indication of treating ocular itching commonly associated with allergen-based conjunctivitis. Similarly, in January 2018, Alocril by Allergan was approved by the USFDA for treating eye itching in allergic conjunctivitis. The proven safety of the drug also allows it to be used on children as young as three. Supportive regulatory environment for ocular therapies and medications are, thus, proving highly beneficial for this market.


Quick Buy -  Allergic Conjunctivitis Market Research Report:

https://www.fortunebusinessinsights.com/checkout-page/100121


Staggering Prevalence of Allergies in the US to Invigorate the North America Market

North America is poised to dominate the allergic conjunctivitis market share during the forecast period on account of the widespread prevalence of different kinds of allergies in the US. For example, according to the Asthma and Allergy Foundation of America, over 50 million Americans are afflicted by allergies annually and allergic conditions are the sixth-leading cause of chronic illnesses in the US. In 2020, the North America market size stood at USD 1.16 billion.

In Europe, on the other hand, the increasing adoption of advanced drugs and treatments for ocular diseases is anticipated to be the foremost growth determinant for the regional market. Meanwhile, in Asia Pacific, the rising incidence of eye allergies will be the prime factor driving the regional market.

Amplifying Customer Reach to be the Dominant Business Strategy

In solidifying their position in the market, key developers of allergic conjunctivitis therapeutics are implementing strategies that can expand their customer reach in a sustained manner. For this, companies are enhancing their distribution networks in various markets and streamlining production capabilities to augment their presence in global value chains.


Have Any Query? Ask Our Experts:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/allergic-conjunctivitis-market-100121


Industry Development

February 2021: After securing approval from the FDA in 2020, Alcon announced that the Pataday Once Daily Relief Extra Strength, the company’s eye allergy solution, is now commercially available across offline and online stores in the US. The FDA clearance allowed the drug to be sold over-the-counter (OTC).

List of Key Players Covered in the Global Market

  • Eton Pharmaceutical (Deer Park, U.S.)
  • Sun Pharmaceutical Industries Ltd. (Mumbai, India)
  • Novartis AG (Basel, Switzerland)
  • Bausch & Lomb Incorporated (Laval, Canada)
  • Allergan (AbbVie Inc.) (North Chicago, U.S.)
  • Ocular Therapeutix, Inc. (Bedford, U.S.)
  • Eyevance Pharmaceuticals LLC (Fort Worth, U.S.)
  • Alcon (Geneva, Switzerland)
  • Santen Pharmaceutical Co., Ltd. (Osaka, Japan)


Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Prevalence of Allergic Conjunctivitis - By Key Countries
    • Pipeline Analysis
    • Key Industry Developments
    • New Product Launches
    • Impact of COVID-19 on the Allergic Conjunctivitis Market
    • Allergy - Statistics and Facts
  • Global Allergic Conjunctivitis Market Analysis, Insights and Forecast, 2017-2028
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Drug Class
      • Antihistamines & Mast Cell Stabilizers  
      • Corticosteroids
      • Others
    • Market Analysis, Insights and Forecast – By Disease Type
      • Mild Allergic Conjunctivitis 
      • Severe Allergic Conjunctivitis
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacies
      • Drug Stores & Retail Pharmacies
      • Online Pharmacies
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
  • North America Allergic Conjunctivitis Market Analysis, Insights and Forecast, 2017-2028
    • Key Findings / Summary
    • Market Analysis – By Drug Class
      • Antihistamines & Mast Cell Stabilizers  
      • Corticosteroids
      • Others
    • Market Analysis, Insights and Forecast – By Disease Type
      • Mild Allergic Conjunctivitis 
      • Severe Allergic Conjunctivitis
    • Market Analysis – By Distribution Channel
      • Hospital Pharmacies
      • Drug Stores & Retail Pharmacies
      • Online Pharmacies
    • Market Analysis – By Country
      • U.S.
      • Canada


Toc Continue..


Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/allergic-conjunctivitis-market-100121


SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:

  • Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies
  • Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.
  • Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility
  • Number of procedures and average price of procedures
  • Replacement rate and pricing of capital equipment
  • Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities
  • Market & technological trends, new product developments, product pipeline.


Have a Look at Related Reports:

Infectious Disease Point-of-care (POC) Diagnostics Market Size, Share & COVID-19 Impact Analysis, By Technique (Lateral Flow Immunoassay, Agglutination Test, Flow-through Test, Molecular Diagnostics), By Disease, By End User, and Regional Forecast 2020-2027

U.S Secondary Hyperparathyroidism (SHPT) Treatment Market Size, Share & Industry Analysis, By Drug Class (Calcimimetics, Vitamin D Analogues, and Phosphate Binders), By Distribution Channel (Hospital & Retail Pharmacies, Online Channels, and Others), and Region Forecast 2019-2026

U.S. Gynecology Robotic Surgery Market Size, Share & COVID-19 Impact Analysis, By Type (Robotic Systems, Instruments and Accessories, and Services), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Physician’s Offices), and Regional Forecast, 2020-2027

Oncology Drugs Market Size, Share & COVID-19 Impact Analysis, By Drugs Class, By Therapy, By Indication, By Dosage Form (Solid, Liquid), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies) and Regional Forecast, 2020-2027

Hunter Syndrome Treatment Market Size, Share & Industry Analysis, By Treatment (Enzyme Replacement Therapy (ERT), and Others), By Route of Administration (Intravenous, and Intracerebroventricular (ICV)/ Intrathecal), By End User (Hospitals, Specialty Clinics and Others), and Regional Forecast, 2019-2026


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.


Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/global-allergic-conjunctivitis-market-10195


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.